{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:56:36Z","timestamp":1790013396475,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11908-019-0669-6","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T09:03:50Z","timestamp":1555405430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Outpatient Parenteral Antimicrobial Therapy in Children"],"prefix":"10.1007","volume":"21","author":[{"given":"Sanjay","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"issue":"2","key":"669_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/jac\/dku401","volume":"70","author":"S Patel","year":"2015","unstructured":"\u2022\u2022 Patel S, Abrahamson E, Goldring S, Green H, Wickens H, Laundy M. Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: a consensus statement. J Antimicrob Chemother. 2015;70(2):360\u201373 An evidence based national guideline covering all the areas involved in setting up and running a pOPAT service.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"669_CR2","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1097\/INF.0000000000002031","volume":"37","author":"S Patel","year":"2018","unstructured":"Patel S, Burzio V, Green H, Rees S, Tebruegge M, Jones C, et al. The impact of pediatric outpatient parenteral antibiotic therapy implementation at a tertiary children\u2019s hospital in the United Kingdom. Pediatr Infect Dis J. 2018;37(12):e292\u2013e7.","journal-title":"Pediatr Infect Dis J"},{"issue":"7213","key":"669_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/bmj.319.7213.845","volume":"319","author":"M Hensher","year":"1999","unstructured":"Hensher M, Edwards N, Stokes R. International trends in the provision and utilisation of hospital care. BMJ. 1999;319(7213):845\u20138.","journal-title":"BMJ"},{"issue":"2","key":"669_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jpc.13100","volume":"52","author":"PA Bryant","year":"2016","unstructured":"Bryant PA, Hopper SM. Alternatives to ward admission from the emergency department. J Paediatr Child Health. 2016;52(2):237\u201340.","journal-title":"J Paediatr Child Health"},{"key":"669_CR5","volume-title":"The community IntraVenous antibiotic study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy","author":"J Minton","year":"2017","unstructured":"Minton J, Murray CC, Meads D, Hess S, Vargas-Palacios A, Mitchell E, et al. The community IntraVenous antibiotic study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy. Southampton: Health Services and Delivery Research; 2017."},{"issue":"7","key":"669_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1357633X13506510","volume":"19","author":"N Bradford","year":"2013","unstructured":"Bradford N, Armfield NR, Young J, Ehmer M, Lawson R, Smith AC. Internet video to support intravenous medication administration in the home: a cost minimisation study. J Telemed Telecare. 2013;19(7):367\u201371.","journal-title":"J Telemed Telecare"},{"issue":"2","key":"669_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/hsc.12512","volume":"26","author":"C Castor","year":"2018","unstructured":"Castor C, Landgren K, Hansson H, Kristensson HI. A possibility for strengthening family life and health: family members\u2019 lived experience when a sick child receives home care in Sweden. Health Soc Care Community. 2018;26(2):224\u201331.","journal-title":"Health Soc Care Community"},{"issue":"9","key":"669_CR8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1086\/597582","volume":"48","author":"H Peltola","year":"2009","unstructured":"Peltola H, Paakkonen M, Kallio P, Kallio MJ. Osteomyelitis-septic arthritis study G. Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis. 2009;48(9):1201\u201310.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"669_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1056\/NEJMra1213956","volume":"370","author":"H Peltola","year":"2014","unstructured":"Peltola H, Paakkonen M. Acute osteomyelitis in children. N Engl J Med. 2014;370(4):352\u201360.","journal-title":"N Engl J Med"},{"issue":"2","key":"669_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamapediatrics.2014.2822","volume":"169","author":"R Keren","year":"2015","unstructured":"Keren R, Shah SS, Srivastava R, Rangel S, Bendel-Stenzel M, Harik N, et al. Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children. JAMA Pediatr. 2015;169(2):120\u20138.","journal-title":"JAMA Pediatr"},{"issue":"2","key":"669_CR11","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1542\/peds.2011-0814","volume":"129","author":"N Bocquet","year":"2012","unstructured":"Bocquet N, Sergent Alaoui A, Jais JP, Gajdos V, Guigonis V, Lacour B, et al. Randomized trial of oral versus sequential IV\/oral antibiotic for acute pyelonephritis in children. Pediatrics. 2012;129(2):e269\u201375.","journal-title":"Pediatrics"},{"key":"669_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00383-018-4343-0","volume":"34","author":"MR Arnold","year":"2018","unstructured":"Arnold MR, Wormer BA, Kao AM, Klima DA, Colavita PD, Cosper GH, et al. Home intravenous versus oral antibiotics following appendectomy for perforated appendicitis in children: a randomized controlled trial. Pediatr Surg Int. 2018;34:1257\u201368.","journal-title":"Pediatr Surg Int"},{"issue":"12","key":"669_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1542\/hpeds.2015-0100","volume":"5","author":"C Stockmann","year":"2015","unstructured":"Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, et al. Comparative effectiveness of Oral versus outpatient parenteral antibiotic therapy for empyema. Hosp Pediatr. 2015;5(12):605\u201312.","journal-title":"Hosp Pediatr"},{"issue":"2","key":"669_CR14","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/jpids\/pix038","volume":"7","author":"AL Hersh","year":"2018","unstructured":"\u2022 Hersh AL, Olson J, Stockmann C, Thorell EA, Knackstedt ED, Esquibel L, et al. Impact of antimicrobial stewardship for pediatric outpatient parenteral antibiotic therapy. J Pediatric Infect Dis Soc. 2018;7(2):e34\u2013e6 Clear demonstration of the importunate of embedding antimicrobial stewardship principles within an pOPAT service; this study describes the impact of expert review on antibiotic use.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"2","key":"669_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1017\/ice.2014.27","volume":"36","author":"ED Knackstedt","year":"2015","unstructured":"Knackstedt ED, Stockmann C, Davis CR, Thorell EA, Pavia AT, Hersh AL. Outpatient parenteral antimicrobial therapy in pediatrics: an opportunity to expand antimicrobial stewardship. Infect Control Hosp Epidemiol. 2015;36(2):222\u20134.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"669_CR16","doi-asserted-by":"crossref","unstructured":"Xu M, Doan Q. Outpatient Parenteral Antimicrobial Therapy and Judicious Use of Pediatric Emergency Resources. Pediatr Emerg Care. 2017.","DOI":"10.1097\/PEC.0000000000001215"},{"issue":"10","key":"669_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1177\/0009922813507999","volume":"53","author":"A Akar","year":"2014","unstructured":"Akar A, Singh N, Hyun DY. Appropriateness and safety of outpatient parenteral antimicrobial therapy in children: opportunities for pediatric antimicrobial stewardship. Clin Pediatr (Phila). 2014;53(10):1000\u20133.","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"669_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/archdischild-2017-313071","volume":"103","author":"AO Mace","year":"2018","unstructured":"Mace AO, McLeod C, Yeoh DK, Vine J, Chen YP, Martin AC, et al. Dedicated paediatric outpatient parenteral antimicrobial therapy medical support: a pre-post observational study. Arch Dis Child. 2018;103(2):165\u20139.","journal-title":"Arch Dis Child"},{"issue":"10","key":"669_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/archdischild-2016-311099","volume":"101","author":"SV Patel","year":"2016","unstructured":"Patel SV. The evolution of outpatient parenteral antibiotic therapy. Arch Dis Child. 2016;101(10):873\u20134.","journal-title":"Arch Dis Child"},{"issue":"3","key":"669_CR20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/QCO.0000000000000449","volume":"31","author":"SV Patel","year":"2018","unstructured":"Patel SV, Vergnano S. The impact of paediatric antimicrobial stewardship programmes on patient outcomes. Curr Opin Infect Dis. 2018;31(3):216\u201323.","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"669_CR21","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/S1473-3099(16)30024-X","volume":"16","author":"BJ McMullan","year":"2016","unstructured":"\u2022\u2022 McMullan BJ, Andresen D, Blyth CC, Avent ML, Bowen AC, Britton PN, et al. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines. Lancet Infect Dis. 2016;16(8):e139\u201352 Evidence based guidelines on the treatment of infections in children.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"669_CR22","first-page":"65","volume":"6","author":"JL Goldman","year":"2017","unstructured":"Goldman JL, Richardson T, Newland JG, Lee B, Gerber JS, Hall M, et al. Outpatient parenteral antimicrobial therapy in pediatric Medicaid enrollees. J Pediatric Infect Dis Soc. 2017;6(1):65\u201371.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"2","key":"669_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/jpids\/pix020","volume":"7","author":"JG Newland","year":"2018","unstructured":"Newland JG, Gerber JS, Kronman MP, Meredith G, Lee BR, Thurm C, et al. Sharing antimicrobial reports for pediatric stewardship (SHARPS): a quality improvement collaborative. J Pediatric Infect Dis Soc. 2018;7(2):124\u20138.","journal-title":"J Pediatric Infect Dis Soc"},{"key":"669_CR24","doi-asserted-by":"crossref","unstructured":"Durojaiye OC, Kritsotakis EI, Johnston P, Kenny T, Ntziora F, Cartwright K. Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy. Clin Microbiol Infect. 2018.","DOI":"10.1016\/j.cmi.2018.11.009"},{"issue":"6","key":"669_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/cid\/cit920","volume":"58","author":"GM Allison","year":"2014","unstructured":"Allison GM, Muldoon EG, Kent DM, Paulus JK, Ruthazer R, Ren A, et al. Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy. Clin Infect Dis. 2014;58(6):812\u20139.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"669_CR26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/emermed-2017-206829","volume":"34","author":"LF Ibrahim","year":"2017","unstructured":"Ibrahim LF, Hopper SM, Connell TG, Daley AJ, Bryant PA, Babl FE. Evaluating an admission avoidance pathway for children in the emergency department: outpatient intravenous antibiotics for moderate\/severe cellulitis. Emerg Med J. 2017;34(12):780\u20135.","journal-title":"Emerg Med J"},{"issue":"2","key":"669_CR27","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/INF.0000000000002070","volume":"38","author":"BT Scanlan","year":"2019","unstructured":"Scanlan BT, Ibrahim LF, Hopper SM, Babl FE, Davidson A, Bryant PA. Selected children with complicated acute urinary tract infection may be treated with outpatient parenteral antibiotic therapy at home directly from the emergency department. Pediatr Infect Dis J. 2019;38(2):e20\u2013e5.","journal-title":"Pediatr Infect Dis J"},{"key":"669_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijporl.2017.09.008","volume":"102","author":"A Alkhateeb","year":"2017","unstructured":"Alkhateeb A, Morin F, Aziz H, Manogaran M, Guertin W, Duval M. Outpatient management of pediatric acute mastoiditis. Int J Pediatr Otorhinolaryngol. 2017;102:98\u2013102.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"8","key":"669_CR29","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/pbc.25012","volume":"61","author":"LM Orme","year":"2014","unstructured":"Orme LM, Babl FE, Barnes C, Barnett P, Donath S, Ashley DM. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial. Pediatr Blood Cancer. 2014;61(8):1427\u201333.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"669_CR30","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S1473-3099(17)30345-6","volume":"18","author":"PA Bryant","year":"2018","unstructured":"\u2022\u2022 Bryant PA, Katz NT. Inpatient versus outpatient parenteral antibiotic therapy at home for acute infections in children: a systematic review. Lancet Infect Dis. 2018;18(2):e45\u201354 An excellent systematic review of the evidence for managing children within pOPAT services.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"669_CR31","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1164\/rccm.201001-0057OC","volume":"182","author":"JM Collaco","year":"2010","unstructured":"Collaco JM, Green DM, Cutting GR, Naughton KM, Mogayzel PJ Jr. Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes. Am J Respir Crit Care Med. 2010;182(9):1137\u201343.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"669_CR32","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ppul.20878","volume":"43","author":"A Termoz","year":"2008","unstructured":"Termoz A, Touzet S, Bourdy S, Decullier E, Bouveret L, Colin C, et al. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections. Pediatr Pulmonol. 2008;43(9):908\u201315.","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"669_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.rmed.2008.08.017","volume":"103","author":"M Proesmans","year":"2009","unstructured":"Proesmans M, Heyns L, Moons P, Havermans T, De Boeck K. Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: outcome of home therapy is not inferior. Respir Med. 2009;103(2):244\u201350.","journal-title":"Respir Med"},{"issue":"4","key":"669_CR34","first-page":"1217","volume":"72","author":"A Jenkins","year":"2017","unstructured":"\u2022 Jenkins A, Hills T, Santillo M, Gilchrist M. Drug Stability Working Group of the BUKOI. Extended stability of antimicrobial agents in administration devices. J Antimicrob Chemother. 2017;72(4):1217\u201320 A review of the literature on the stability of antimicrobials within elastomeric devices. Demonstrates a paucity of high-quality stability data.","journal-title":"J Antimicrob Chemother"},{"key":"669_CR35","doi-asserted-by":"crossref","unstructured":"\u2022 Allwood MC, Stonkute D, Wallace A, Wilkinson A-S, Hills T, Jamieson C. Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements. 2018:ejhpharm-2018-001515. Data on flucloxacillin stability over 24-hours within 2 different elastomeric devices. Demonstrates the importance of citrate-buffering to ensure drug stability over a 24 hour period.","DOI":"10.1136\/ejhpharm-2018-001515"},{"key":"669_CR36","doi-asserted-by":"crossref","unstructured":"Jamieson C, Allwood MC, Stonkute D, Wallace A, Wilkinson A-S, Hills T. Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting. 2019:ejhpharm-2018-001699.","DOI":"10.1136\/ejhpharm-2018-001699"},{"issue":"5","key":"669_CR37","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1128\/AAC.02637-13","volume":"58","author":"P Bourget","year":"2014","unstructured":"Bourget P, Amin A, Dupont C, Abely M, Desmazes-Dufeu N, Dubus JC, et al. How to minimize toxic exposure to pyridine during continuous infusion of ceftazidime in patients with cystic fibrosis? Antimicrob Agents Chemother. 2014;58(5):2849\u201355.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"669_CR38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/INF.0b013e31817d32f2","volume":"27","author":"P Van Winkle","year":"2008","unstructured":"Van Winkle P, Whiffen T, Liu IL. Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital. Pediatr Infect Dis J. 2008;27(12):1069\u201372.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"669_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/0009922806290328","volume":"46","author":"S Hussain","year":"2007","unstructured":"Hussain S, Gomez MM, Wludyka P, Chiu T, Rathore MH. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila). 2007;46(3):247\u201351.","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"669_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1017\/ice.2015.317","volume":"37","author":"A Kovacich","year":"2016","unstructured":"Kovacich A, Tamma PD, Advani S, Popoola VO, Colantuoni E, Gosey L, et al. Peripherally inserted central venous catheter complications in children receiving outpatient parenteral antibiotic therapy (OPAT). Infect Control Hosp Epidemiol. 2016;37(4):420\u20134.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"669_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/INF.0000000000001716","volume":"37","author":"P Fernandes","year":"2018","unstructured":"Fernandes P, Milliren C, Mahoney-West HM, Schwartz L, Lachenauer CS, Nakamura MM. Safety of outpatient parenteral antimicrobial therapy in children. Pediatr Infect Dis J. 2018;37(2):157\u201363.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"669_CR42","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/archdischild-2015-309731","volume":"101","author":"KA Hodgson","year":"2016","unstructured":"Hodgson KA, Huynh J, Ibrahim LF, Sacks B, Golshevsky D, Layley M, et al. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy. Arch Dis Child. 2016;101(10):886\u201393.","journal-title":"Arch Dis Child"},{"issue":"1","key":"669_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/INF.0000000000001351","volume":"36","author":"D Yusef","year":"2017","unstructured":"Yusef D, Gonzalez BE, Foster CB, Goldfarb J, Saracusa C, Worley S, et al. Piperacillin-Tazobactam-induced adverse drug events in pediatric patients on outpatient parenteral antimicrobial therapy. Pediatr Infect Dis J. 2017;36(1):50\u20132.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"669_CR44","first-page":"279","volume":"20","author":"EA Chrysochoou","year":"2016","unstructured":"Chrysochoou EA, Hatziagorou E, Kirvassilis F, Tsanakas J. Home intravenous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit. Hippokratia. 2016;20(4):279\u201383.","journal-title":"Hippokratia"},{"issue":"4","key":"669_CR45","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1542\/peds.2004-0421","volume":"114","author":"M Gauthier","year":"2004","unstructured":"Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Pediatrics. 2004;114(4):e469\u201376.","journal-title":"Pediatrics"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-019-0669-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-019-0669-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-019-0669-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T13:29:15Z","timestamp":1607261355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-019-0669-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1007\/s11908-019-0669-6","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"assertion":[{"value":"16 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Sanjay Patel and Helen Green declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"17"}}